title: [Successful treatment of one case with relapsed refractory multiple myeloma by chidamide in combination with bortezomib and dexamethasone].
authors.forename: D Y
authors.initials: DY
authors.lastname: Wang
authors.forename: Y S
authors.initials: YS
authors.lastname: Cui
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Liu
authors.forename: L N
authors.initials: LN
authors.lastname: Liu
authors.forename: Y P
authors.initials: YP
authors.lastname: Song
authors.forename: B J
authors.initials: BJ
authors.lastname: Fang
mesh_terms: D000631:Aminopyridines / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D000069286:Bortezomib / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*
chemical_list: D000631:Aminopyridines; D001549:Benzamides; D000069286:Bortezomib; D003907:Dexamethasone; C547816:N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide